ectoine has been researched along with Inflammatory Bowel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aziz, H; Efferth, T; Khayyal, MT; Scherner, O; Wadie, W | 1 |
| Bethlehem, L; van Echten-Deckert, G | 1 |
1 review(s) available for ectoine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Ectoines as novel anti-inflammatory and tissue protective lead compounds with special focus on inflammatory bowel disease and lung inflammation.
Topics: Amino Acids, Diamino; Animals; Anti-Inflammatory Agents; Biological Availability; Drug Delivery Systems; Eukaryota; Humans; Inflammatory Bowel Diseases; Lung Diseases; Prokaryotic Cells | 2021 |
1 other study(ies) available for ectoine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease.
Topics: Amino Acids, Diamino; Animals; Bacteria; Colitis; Colon; Egypt; Glutathione; Humans; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Interleukin-1beta; Intestines; Male; Molecular Structure; Peroxidase; Rats; Rats, Wistar; Solutions; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2015 |